Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Luo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncology Research|June 15, 1999
Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cellsF R Luo, S D Wyrick, S G Chaney
Cancer Chemotherapy and Pharmacology|June 15, 1999
Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in ratsF R Luo, S D Wyrick, S G Chaney
Cancer Chemotherapy and Pharmacology|June 15, 1999
Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture modelF R Luo, S D Wyrick, S G Chaney
Journal of Biochemical and Molecular Toxicology|March 31, 1999
Biotransformations of oxaliplatin in rat blood in vitroF R Luo, S D Wyrick, S G Chaney
Journal of Chromatography. B, Biomedical Sciences and Applications|April 29, 1999
High-performance liquid chromatographic separation of the biotransformation products of oxaliplatinF R Luo, T Y Yen, S D Wyrick, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograftF R Luo, Z Yang, H Dong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncology Research|June 15, 1999
Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cellsF R Luo, S D Wyrick, S G Chaney
Cancer Chemotherapy and Pharmacology|June 15, 1999
Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in ratsF R Luo, S D Wyrick, S G Chaney
Cancer Chemotherapy and Pharmacology|June 15, 1999
Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture modelF R Luo, S D Wyrick, S G Chaney
Journal of Biochemical and Molecular Toxicology|March 31, 1999
Biotransformations of oxaliplatin in rat blood in vitroF R Luo, S D Wyrick, S G Chaney
Journal of Chromatography. B, Biomedical Sciences and Applications|April 29, 1999
High-performance liquid chromatographic separation of the biotransformation products of oxaliplatinF R Luo, T Y Yen, S D Wyrick, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograftF R Luo, Z Yang, H Dong, et al.
Pageof 1